Innovating Works
BBDiag: Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease UNIVERSITY OF PLYMOUTH tramitó un H2020: Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensive efforts, no disease-modifying treatments or preventive str...
2017-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.